RASD1
Basic information
Region (hg38): 17:17494437-17496395
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RASD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 0 | 0 |
Variants in RASD1
This is a list of pathogenic ClinVar variants found in the RASD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-17495165-C-T | not specified | Uncertain significance (Jan 17, 2023) | ||
17-17495216-C-A | not specified | Uncertain significance (Sep 22, 2023) | ||
17-17495226-A-C | not specified | Uncertain significance (Apr 23, 2024) | ||
17-17495232-C-T | not specified | Uncertain significance (Aug 08, 2022) | ||
17-17495265-C-T | not specified | Uncertain significance (May 16, 2023) | ||
17-17495342-G-A | not specified | Uncertain significance (May 07, 2024) | ||
17-17495431-C-G | not specified | Uncertain significance (Jan 03, 2024) | ||
17-17495447-T-G | not specified | Uncertain significance (Oct 26, 2021) | ||
17-17495496-C-G | not specified | Uncertain significance (Jun 18, 2021) | ||
17-17495627-T-C | not specified | Uncertain significance (Jun 11, 2024) | ||
17-17495980-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
17-17495985-G-C | not specified | Uncertain significance (Apr 07, 2023) | ||
17-17495986-A-G | not specified | Uncertain significance (Apr 07, 2023) | ||
17-17496013-T-C | not specified | Uncertain significance (Nov 09, 2021) | ||
17-17496040-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
17-17496046-T-A | not specified | Uncertain significance (Apr 29, 2024) | ||
17-17496085-A-G | not specified | Uncertain significance (Apr 07, 2023) | ||
17-17496087-G-A | not specified | Uncertain significance (May 17, 2023) | ||
17-17496097-T-C | not specified | Uncertain significance (Apr 07, 2023) | ||
17-17496115-T-G | not specified | Uncertain significance (Apr 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RASD1 | protein_coding | protein_coding | ENST00000225688 | 2 | 1959 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0387 | 0.848 | 125555 | 0 | 17 | 125572 | 0.0000677 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.374 | 160 | 174 | 0.920 | 0.00000797 | 1850 |
Missense in Polyphen | 48 | 64.828 | 0.74042 | 672 | ||
Synonymous | 0.281 | 72 | 75.1 | 0.959 | 0.00000356 | 550 |
Loss of Function | 1.28 | 3 | 6.53 | 0.460 | 2.76e-7 | 82 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000149 | 0.000149 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000109 | 0.000106 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000335 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Small GTPase. Negatively regulates the transcription regulation activity of the APBB1/FE65-APP complex via its interaction with APBB1/FE65 (By similarity). {ECO:0000250}.;
- Pathway
- Cushing,s syndrome - Homo sapiens (human);Circadian entrainment - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.960
Intolerance Scores
- loftool
- 0.451
- rvis_EVS
- -0.32
- rvis_percentile_EVS
- 31.46
Haploinsufficiency Scores
- pHI
- 0.194
- hipred
- Y
- hipred_score
- 0.866
- ghis
- 0.560
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.854
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rasd1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- signal transduction;G protein-coupled receptor signaling pathway;nitric oxide mediated signal transduction;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;plasma membrane;sarcoplasmic reticulum;perinuclear region of cytoplasm
- Molecular function
- GTPase activity;protein binding;GTP binding